Cellectis (CLLS) Capital Expenditures (2015 - 2026)
Cellectis (CLLS) posted Capital Expenditures of -$265000.0 for Q1 2026, down 114.09% on a QoQ basis from $1.9 million in Q4 2025, and up 32.91% year-over-year from -$199381.0 in Q1 2025.
Cellectis (CLLS) has 12 years of Capital Expenditures data on file, last reported at -$265000.0 in Q1 2026.
- In Q1 2026, Capital Expenditures rose 32.91% year-over-year to -$265000.0; the TTM figure through Mar 2026 stood at $130000.0 (down 94.6% YoY), while the FY2024 annual figure was $2.6 million, changed N/A from the prior year.
- Capital Expenditures fell to -$265000.0 in Q1 2026, from $1.9 million in the prior quarter.
- Across five years, Capital Expenditures topped out at $4.6 million in Q4 2024 and bottomed at -$1.2 million in Q3 2025.
- A 5-year average of $279352.9 and a median of -$305000.0 in 2025 frame the typical range for Capital Expenditures.
- The widest YoY moves for Capital Expenditures: up 479.17% in 2024, down 284.44% in 2024.
- Year by year, Capital Expenditures stood at $4.4 million in 2022, then plunged by 81.97% to $797000.0 in 2023, then jumped by 479.17% to $4.6 million in 2024, then tumbled by 59.25% to $1.9 million in 2025, then tumbled by 114.09% to -$265000.0 in 2026.
- The last three Capital Expenditures figures came in at -$265000.0 (Q1 2026), $1.9 million (Q4 2025), and -$1.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 133.40 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 230.60 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 21.83 Mn |
| 10 | Cellectis | 20.83 Bn | 20.62 Bn | - | -265,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -265,000.00 |
| Mar 31, 2026 | -265,000.00 |
| Dec 31, 2025 | 1.88 Mn |
| Dec 31, 2025 | 1.88 Mn |
| Sep 30, 2025 | -1.18 Mn |
| Sep 30, 2025 | -1.18 Mn |
| Jun 30, 2025 | -305,000.00 |
| Jun 30, 2025 | -305,000.00 |
| Mar 31, 2025 | -395,000.00 |
| Mar 31, 2025 | -395,000.00 |
| Dec 31, 2024 | 4.62 Mn |
| Dec 31, 2024 | 4.62 Mn |
| Sep 30, 2024 | -777,000.00 |
| Sep 30, 2024 | -777,000.00 |
| Jun 30, 2024 | -1.04 Mn |
| Jun 30, 2024 | -1.04 Mn |
| Mar 31, 2024 | -218,000.00 |
| Mar 31, 2024 | -218,000.00 |
| Dec 31, 2023 | 797,000.00 |
| Dec 31, 2023 | 797,000.00 |
| Sep 30, 2023 | -314,000.00 |
| Sep 30, 2023 | -314,000.00 |
| Jun 30, 2023 | -270,000.00 |
| Jun 30, 2023 | -270,000.00 |
| Mar 31, 2023 | -213,000.00 |
| Mar 31, 2023 | -213,000.00 |
| Dec 31, 2022 | 4.42 Mn |
| Dec 31, 2022 | 4.42 Mn |
| Sep 30, 2022 | -448,000.00 |
| Sep 30, 2022 | -448,000.00 |
| Jun 30, 2022 | -915,000.00 |
| Jun 30, 2022 | -915,000.00 |
| Mar 31, 2022 | -626,000.00 |
| Mar 31, 2022 | -626,000.00 |
| Dec 31, 2021 | 36.80 Mn |
| Dec 31, 2021 | 36.80 Mn |
| Sep 30, 2021 | -4.61 Mn |
| Sep 30, 2021 | -4.61 Mn |
| Jun 30, 2021 | -5.45 Mn |
| Jun 30, 2021 | -5.45 Mn |
| Mar 31, 2021 | -8.19 Mn |
| Mar 31, 2021 | -8.19 Mn |
| Dec 31, 2020 | 72.30 Mn |
| Dec 31, 2020 | 72.30 Mn |
| Sep 30, 2020 | -6.34 Mn |
| Sep 30, 2020 | -6.34 Mn |
| Jun 30, 2020 | -13.98 Mn |
| Jun 30, 2020 | -13.98 Mn |
| Mar 31, 2020 | -7.91 Mn |
| Mar 31, 2020 | -7.91 Mn |
| Dec 31, 2019 | 23.19 Mn |
| Dec 31, 2019 | 23.19 Mn |
| Sep 30, 2019 | -5.47 Mn |
| Sep 30, 2019 | -5.47 Mn |
| Jun 30, 2019 | -3.00 Mn |
| Jun 30, 2019 | -3.00 Mn |
| Mar 31, 2019 | -1.81 Mn |
| Mar 31, 2019 | -1.81 Mn |
| Dec 31, 2018 | 7.13 Mn |
| Dec 31, 2018 | 7.13 Mn |
| Sep 30, 2018 | -1.23 Mn |
| Sep 30, 2018 | -1.23 Mn |
| Jun 30, 2018 | -551,000.00 |
| Jun 30, 2018 | -551,000.00 |
| Mar 31, 2018 | -635,000.00 |
| Mar 31, 2018 | -635,000.00 |
| Dec 31, 2017 | 4.25 Mn |
| Dec 31, 2017 | 4.25 Mn |
| Sep 30, 2017 | -586,000.00 |
| Sep 30, 2017 | -586,000.00 |
| Jun 30, 2017 | -1.00 Mn |
| Jun 30, 2017 | -1.00 Mn |
| Mar 31, 2017 | -546,000.00 |
| Mar 31, 2017 | -546,000.00 |
| Dec 31, 2016 | 26.26 Mn |
| Dec 31, 2016 | 26.26 Mn |
| Sep 30, 2016 | -2.48 Mn |
| Sep 30, 2016 | -2.48 Mn |
| Jun 30, 2016 | -2.72 Mn |
| Jun 30, 2016 | -2.72 Mn |
| Mar 31, 2016 | -7.31 Mn |
| Mar 31, 2016 | -7.31 Mn |
| Dec 31, 2015 | -629,171.32 |
| Dec 31, 2015 | -629,171.32 |
| Sep 30, 2015 | -195,762.14 |
| Sep 30, 2015 | -195,762.14 |
| Jun 30, 2015 | -436,530.80 |
| Jun 30, 2015 | -436,530.80 |
| Mar 31, 2015 | -3.10 Mn |
| Mar 31, 2015 | -3.10 Mn |